All Updates

All Updates

icon
Filter
Funding
Bon Vivant raises EUR 15.9 million in a seed funding round
Plant-based Dairy & Egg
Oct 11, 2023
This week:
Management news
6K Additive awarded project to develop C-103 powder for additive manufacturing
Additive Manufacturing
Sep 27, 2024
Partnerships
WAAM3D partners with Innovative Space Carrier, Cranfield University, and Aichi Sangyo for space transport development
Additive Manufacturing
Sep 19, 2024
Product updates
Microsoft launches Face Check with Microsoft Entra Verified ID
Facial Recognition
Sep 11, 2024
Funding
3DEO raises USD 3.5 million in strategic investment from Mizuho Bank
Additive Manufacturing
Sep 6, 2024
Product updates
HyperWrite launches open-source AI model Reflection 70 billion
Generative AI Applications
Sep 5, 2024
Product updates
Google begins US rollout of AI-powered Ask Photos feature
Generative AI Applications
Sep 5, 2024
Funding
Management news
HDAX Therapeutics raises USD 3.2 million in seed funding to progress pipeline and advance preclinical candidates into trials
Precision Medicine
Sep 5, 2024
Partnerships
Sequentify partners with Dexter to expand genomic diagnostics in Romania
Precision Medicine
Sep 5, 2024
Partnerships
Elevate partners with Cultivatd for European expansion
Vertical Farming
Sep 5, 2024
Product updates
Moolec confirms harvest of its genetically engineered plant-grown products
Crop Biotech
Sep 5, 2024
Plant-based Dairy & Egg

Plant-based Dairy & Egg

Oct 11, 2023

Bon Vivant raises EUR 15.9 million in a seed funding round

Funding

  • French precision fermentation startup Bon Vivant has raised EUR 15 million (~USD 15.9 million) in seed funding led by Sofinnova Partners and Sparkfood, with participation from Captech Santé, Alliance for Impact, High Flyers Capital, Kima Ventures, Founders Future, and Picus Capital.

  • The funding will be used to scale production capacity, obtain regulatory clearances to commercialize its animal-free milk proteins and open a new lab in Lyon to develop samples for prospective clients.

  • Bon Vivant uses biotechnology to reprogram yeast microorganisms to produce animal-free milk proteins with a lower environmental footprint than traditional dairy. The company aims to launch its milk proteins in the US market in 2025, focusing on B2B customers in the foodservice sector.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.